Guidelines of care for the management of psoriasis and psoriatic arthritis

摘要: Psoriasis is a common, chronic, inflammatory, multi-system disease with predominantly skin and joint manifestations affecting approximately 2% of the population. In this third 6 sections guidelines care for psoriasis, we discuss use topical medications treatment psoriasis. The majority patients psoriasis have limited (<5% body surface area involvement) can be treated agents, which generally provide high efficacy-to-safety ratio. Topical agents may also used adjunctively more extensive undergoing therapy either ultraviolet light, systemic or biologic medications. However, as monotherapy in setting limited, but recalcitrant, not routinely recommended. Treatment should tailored to meet individual patients' needs. We will efficacy safety well offer recommendations corticosteroids, vitamin D analogues, tazarotene, tacrolimus, pimecrolimus, emollients, salicylic acid, anthralin, coal tar, combination therapy.